On Tuesday, Shares of Koninklijke Philips NV (ADR) (NYSE:PHG), gained 0.43% to $23.29.
Royal Philips, declared new study results demonstrating an insightful correlation between chronic conditions and falls risk. Philips’ researchers retrospectively analyzed the records of 145,000 seniors equipped with a standard Philips Lifeline medical alert service or a medical alert service with AutoAlert (automatic fall detection) between January 2012 and June 2014. Data showed seniors with chronic conditions fell and required emergency transport up to 54 percent more often, contrast to their peers with no chronic conditions. Additionally, the analysis revealed that seniors with physical conditions not typically tied to frailty, counting COPD and diabetes, also were shown to fall more often.
In the United States, one in three seniors fall each year and about 75 percent of healthcare costs are spent on chronic diseases. Understanding the fall risk associated with seniors, especially those living with chronic conditions, is the first step to prevention, and by providing prompt care, outcomes can be improved and costs related to direct medical assistance better managed. Driving visibility to the need to take preventative steps can assist this population prepare appropriately and assist them get fast access to assist when needed.
“While conditions like Parkinson’s disease and osteoporosis are more obviously tied to falls, we’re learning that other common chronic diseases, like diabetes and COPD, have a direct correlation to raised frailty and falls,” said Kimberly O’Loughlin, Senior Vice President and General Manager of Home Monitoring, Philips. “As we use better, more personal information, we will be able to do an increasingly better job of keeping our loved ones safer and healthier in their homes.”
Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, counting radiation oncology and portfolio administration; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products.
Shares of Cempra Inc (NASDAQ:CEMP), declined -11.81% to $24.65, during its last trading session.
Cempra, declared it will be making a poster presentation at the European Respiratory Society (ERS) International Congress, being held in Amsterdam from September 26-30, 2015.
Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates comprise solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community attained bacterial pneumonia, in addition to for uncomplicated bacterial urethritis; and Taksta (CEM-102), an antibiotic that has accomplished Phase II clinical trials for refractory bone and joint infections.
At the end of Tuesday’s trade, Shares of Splunk Inc (NASDAQ:SPLK), gained 0.78% to $54.44.
Splunk Inc., declared updates to several products counting Splunk MINT, Splunk Light™ and Hunk®.
“At .conf2015, we are showcasing innovations across our entire portfolio of software and cloud solutions, and Hunk, Splunk Light and Splunk MINT are important pillars of our customers’ overall data strategy,” said Shay Mowlem, vice president product administration and product marketing, Splunk. “Splunk MINT and Hunk assist organizations gain value from two of the fastest-growing sources of data, mobile data and historical data in Hadoop. Small IT teams can also now utilize Splunk Light as a cloud service.”
Splunk, Inc. provides software products that enable organizations to gain real-time operational intelligence in the United States and internationally. The company’s products enable users to collect, index, search, explore, monitor, and analyze data regardless of format or source users.
Finally, Tegna Inc (NYSE:TGNA), ended its last trade with -1.75% loss, and closed at $21.85.
TEGNA, companies PointRoll and Shoplocal declared they have come together to form a single new brand, Cofactor. Cofactor combines the products, DNA and expertise of Shoplocal and PointRoll and uniquely enables brands to bridge the divide between online and offline worlds, through the intelligent delivery of content everywhere, driving sales locally.
Additionally, the Cofactor Content Activation Engine launch is a first of its kind solution within the ad tech industry. This product expands Cofactor’s reach beyond its retail industry leading Shoplocal API. The Cofactor Content Activation Engine enables brands to easily onboard all of their content, activate and dynamically distribute it cross-channel. For marketers, promoting the brand and driving sales have often been an either-or proposition. Cofactor’s 5,000 customers, like Target, Walgreens, Walmart, P&G, Nissan and Audi, no longer have to choose and now have the means to effectively activate cross-channel communications to drive personalization, relevancy and sales.
TEGNA Inc. engages in media and digital businesses in the United States. The company operates 46 television stations that produce local programming, such as news, sports, and entertainment; and associated online sites.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
